In the good-news/bad-news world of blockbuster drugs, the latest is the launch of Sovaldi, a drug to treat hepatitis C.
Sovaldi comes with a cure rate as high as 90% for a disease that afflicts 3 million people in the United States, and with fewer complications than previous treatments.
But it also comes with a scary side effect: a price of $1,000 a pill.
Read More